
Using AI for Translation: Stay MDR-Compliant
Are you using Machine Translation or AI to translate medical device documentation? Wondering whether that could lead to non-compliance with Regulation (EU) 2017/745 (MDR)? Here’s what you need to know.
We support global pharmaceutical companies looking to launch drugs in overseas markets with our translation and localization services.
Developing new drugs is a lengthy process that costs pharmaceutical companies millions of euros in investment. It can take as much as 10 years from the beginning of the research phase until the market launch.
More than 50% of the
investment spending
is allocated to the design, development, and evaluation of phases 1, 2, and 3 of clinical trials.
Only 1 in 5 drugs
that reach the market is able to generate revenues that exceed the overall R&D costs.
We facilitate the onboarding and professional development of your sales team by translating and adapting your training materials to each local market.
We’ve been supporting marketing departments in pharmaceutical companies with new product launches for +15 years.
Let’s talk about your next project!
Translation
Interpreting
Localization
Other services
Using AI for Translation: Stay MDR-Compliant
Are you using Machine Translation or AI to translate medical device documentation? Wondering whether that could lead to non-compliance with Regulation (EU) 2017/745 (MDR)? Here’s what you need to know.